Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies Inc. held its annual meeting of shareholders, where candidates for the Board of Directors were elected and KPMG LLP was appointed as auditors.

Rhea-AI Summary

Theratechnologies Inc. held its annual meeting of shareholders, where candidates for the Board of Directors were elected and KPMG LLP was appointed as auditors. The voting results showed high support for all candidates, with Frank Holler becoming the new Chair of the Board.

Argus Session date unavailable

-3.17% session move Open Argus

Details

News Market Reaction – THTX

The recorded move for THTX in the trading session of this news was -3.17%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.

Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:

	FOR		% FOR		ABSTENTION		% ABSTENTION
Joseph Arena	22,405,047		93.09	%	1,663,754		6.91	%
Frank Holler	21,008,601		87.29	%	3,060,200		12.71	%
Paul Lévesque	20,966,427		87.11	%	3,102,374		12.89	%
Andrew Molson	21,067,050		87.53	%	3,001,751		12.47	%
Dawn Svoronos	20,964,213		87.10	%	3,104,588		2.90	%
Elina Tea	21,734,254		90.30	%	2,334,547		9.70	%
Dale Weil	21,009,681		87.29	%	3,059,120		12.71	%
Jordan Zwick	23,107,383		96.01	%	961,418		3.99	%

Frank Holler will now act as Chair of the Board of Directors of the Company.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who were elected to Theratechnologies' Board of Directors at the annual meeting of shareholders?

Joseph Arena, Frank Holler, Paul Lévesque, Andrew Molson, Dawn Svoronos, Elina Tea, Dale Weil, and Jordan Zwick were elected.

Who was appointed as the auditors for Theratechnologies for the current fiscal year?

KPMG LLP was appointed as the auditors for the current fiscal year.

Who is the new Chair of the Board of Directors of Theratechnologies?

Frank Holler is the new Chair of the Board of Directors.